-
EP4301744
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4301744
| EP4301744 - NICOTINAMIDE RIPK1 INHIBITORS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 09.02.2024 Database last updated on 24.07.2024 | |
| Former | Request for examination was made Status updated on 08.12.2023 | ||
| Former | The international publication has been made Status updated on 17.02.2023 | ||
| Former | unknown Status updated on 03.10.2022 | Most recent event Tooltip | 03.06.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US | [2024/02] | Inventor(s) | 01 /
CUSACK, Kevin, Patrick Worcester, MA 01605 / US | 02 /
HOEMANN, Michael, Zeller Worcester, MA 01605 / US | 03 /
KINSMAN, David, Andrew Worcester, MA 01605 / US | 04 /
OSMAN, Sami Worcester, MA 01605 / US | 05 /
STAMBULI, James, Patrick Worcester, MA 01605 / US | 06 /
ARGIRIADI, Maria, Anastasia Worcester, MA 01605 / US | 07 /
O'REILLY, Ciaran Nottingham NG1 1GR / GB | 08 /
DEXTER, Hannah Nottingham NG1 1GR / GB | 09 /
FORDYCE, Euan Nottingham NG1 1GR / GB | 10 /
ST. GALLAY, Steve Nottingham NG1 1GR / GB | [2024/02] | Representative(s) | Schlich, George, et al Schlich 9 St Catherine's Road Littlehampton, West Sussex BN17 5HS / GB | [2024/02] | Application number, filing date | 22777032.8 | 08.08.2022 | [2024/02] | WO2022US39689 | Priority number, date | US202163231590P | 10.08.2021 Original published format: US 202163231590 P | [2024/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023018643 | Date: | 16.02.2023 | Language: | EN | [2023/07] | Type: | A1 Application with search report | No.: | EP4301744 | Date: | 10.01.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.02.2023 takes the place of the publication of the European patent application. | [2024/02] | Search report(s) | International search report - published on: | EP | 16.02.2023 | Classification | IPC: | C07D401/06, C07D405/06, C07D413/06, C07D417/06, A61K31/455, A61P29/00 | [2024/02] | CPC: |
C07D401/06 (EP,IL,KR,US);
A61K31/4439 (KR);
A61K31/5383 (KR);
A61K31/675 (KR);
A61P1/04 (IL,KR,US);
C07D405/06 (EP,IL);
C07D405/14 (IL,KR,US);
C07D413/06 (EP,IL,KR,US);
C07D417/06 (EP,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/02] | Extension states | BA | 04.10.2023 | ME | 04.10.2023 | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | NICOTINAMID-RIPK1-INHIBITOREN | [2024/02] | English: | NICOTINAMIDE RIPK1 INHIBITORS | [2024/02] | French: | INHIBITEURS DE NICOTINAMIDE RIPK1 | [2024/02] | Entry into regional phase | 04.10.2023 | National basic fee paid | 04.10.2023 | Designation fee(s) paid | 04.10.2023 | Examination fee paid | Examination procedure | 04.10.2023 | Amendment by applicant (claims and/or description) | 04.10.2023 | Examination requested [2024/02] | 04.10.2023 | Date on which the examining division has become responsible | 08.02.2024 | Despatch of a communication from the examining division (Time limit: M06) |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2020149553 (VORONOI CO LTD [KR], et al) |